Trial Profile
Retrospective study of dabigatran in patients with atrial fibrillation.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Apr 2017
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary)
- Indications Embolism; Stroke
- Focus Adverse reactions
- 17 Mar 2017 New trial record